BlackRock Advisors’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $12K | Hold |
2,227
| – | – | ﹤0.01% | 3472 |
|
|
2016
Q3 | $56K | Buy |
2,227
+33
| +2% | +$830 | ﹤0.01% | 3146 |
|
|
2016
Q2 | $54K | Hold |
2,194
| – | – | ﹤0.01% | 3155 |
|
|
2016
Q1 | $64K | Buy |
2,194
+232
| +12% | +$6.77K | ﹤0.01% | 3045 |
|
|
2015
Q4 | $73K | Sell |
1,962
-1,092
| -36% | -$40.6K | ﹤0.01% | 3015 |
|
|
2015
Q3 | $149K | Buy |
3,054
+380
| +14% | +$18.5K | ﹤0.01% | 2850 |
|
|
2015
Q2 | $184K | Buy |
+2,674
| New | +$184K | ﹤0.01% | 2797 |
|
|
2014
Q3 | – | Sell |
-790
| Closed | -$21K | – | 3683 |
|
|
2014
Q2 | $21K | Hold |
790
| – | – | ﹤0.01% | 3408 |
|
|
2014
Q1 | $21K | Hold |
790
| – | – | ﹤0.01% | 3385 |
|
|
2013
Q4 | $19K | Buy |
790
+345
| +78% | +$8.3K | ﹤0.01% | 3382 |
|
|
2013
Q3 | $14K | Buy |
445
+290
| +187% | +$9.12K | ﹤0.01% | 3384 |
|
|
2013
Q2 | $5K | Buy |
+155
| New | +$5K | ﹤0.01% | 3517 |
|